Skip to main content

Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children

Journal of Endocrinological Investigation volume 16, pages 521–525 (1993)Cite this article

Abstract

Aim of this study was to verify whether arginine (ARG), which likely inhibits hypothalamic somatostatin release, has an enhancing effect on the GHRH-induced GH rise, even when administered orally at low dose. To this goal we studied the effects of 4 g orally administered ARG, either hydrochloride (ARG-H) or aspartate (ARG-A), on both basal and GHRH (1 μg/Kg iv) -stimulated GH secretion in 31 children with familial short stature (11 males and 20 females, aged 5.5–13.8 yr, pubertal stage l–lll, and compared the results with those of iv infusion of 0.5 g/kg ARG-H. Oral ARG-H (Group A,n=11) induced a significant increase of basal GH levels (4.2±1.3 vs 1.0±0.4 μg/L, p<0.02) and enhanced the GH response to GHRH (41.1±8.6 vs 25.3±6.7 μg/L, p<0.02). Oral ARG-A (Group B, n=10) induced a slight, but not statistically significant increase in serum GH levels (3.4±1.5 vs 1.0±0.3 μg/L) and enhanced the GHRH-induced GH rise (49.7±9.8 vs 26.1±8.4 μg/L, p<0.05).Intravenous ARG-H (Group C, n=10) stimulated basal GH levels (6.2±1.2 vs 1.2±0.3 μg/L, p<0.005) and increased the GHRH-induced GH rise (46.7±5.0 vs 17.1 ± 2.3 μg/L, p<0.005). This response was similar to those after oral ARG-H or ARG-A plus GHRH. No variation was observed in PRL levels after oral ARG (either ARG-H or ARG-A) and/or GHRH. These results show that a low dose of orally administered ARG is able to enhance the GHRH-induced GH rise with the same extent of a high dose iv administered ARG in normal short children. The potential usefulness of oral ARG combined with GHRH to restore GH secretion in hypothalamic GH deficiency might be envisaged.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Müller E.E., Nisticò G. Brain messengers and the pituitary. Academic Press, San Diego, 1989.

    Google Scholar 

  2. Knopf. R.F., Conn J.W., Fajans S.G., Floyd J.C., Guntsche E.M., Rull J.A. Plasma growth hormone response to intravenous administration of aminoacids. J. Clin. Endocrinol. Metab. 25: 1140, 1965.

    Article  CAS  PubMed  Google Scholar 

  3. Kuhara T., Hikeda S., Ohneda A., Sasaki Y. Effects of intravenous infusion of 17 aminoacids on the secretion of GH, glucagon and insulin in sheep. Am. J. Physiol. 260: E21, 1991.

    CAS  PubMed  Google Scholar 

  4. Merimeé T.J., Rabinowiz D., Fineberg S.E. Arginine initiates release of human growth hormone, factors modifying the response in normal man. N. Engl. J. Med. 280: 1434, 1960.

    Article  Google Scholar 

  5. Parker M.L., Hammonds J.M., Daughaday W.A. The arginine provocative test: an aid in the diagnosis of hyposomatotropinism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.

    Article  CAS  PubMed  Google Scholar 

  6. Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., De Sanctis C., Camanni F. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin. Endocrinol. (Oxf.) 32: 763, 1990.

    Article  CAS  Google Scholar 

  7. Ghigo E., Arvat E., Valente F., Nicolosi M., Boffano G.M., Procopio M., Bellone J., Maccario M., Mazza E., Camanni F. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54: 291, 1991.

    Article  CAS  PubMed  Google Scholar 

  8. Ghigo E., Goffi S., Nicolosi M., Arvat E., Valente F., Mazza E., Ghigo M.C., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.

    Article  CAS  PubMed  Google Scholar 

  9. Ghigo E., Arvat E., Goffi S., Bellone J., Valente F., Procopio M., Ghigo M.C. Camanni F. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotroph cells during lifespan. Exp. Clin. Endocrinol. (Life Sci. Adv.) 10: 191, 1991.

    Google Scholar 

  10. Alba Roth J., Albrecht Müller O., Schopohl J., Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.

    Article  CAS  PubMed  Google Scholar 

  11. Page M.D., Dieguez C., Valcavi R., Edwards C., Halk R., Scanion M.F. Growth hormone (GH) response to arginine and I-dopa alone and after GHRH pretreatment. Clin. Endocrinol. (Oxf.) 28: 551, 1988.

    Article  CAS  Google Scholar 

  12. Skare S., Hanssen K.F., Kriz V., Torjesen P.A. Arginine infusion increases peripheral plasma somatostatin in man. Clin. Endocrinol. (Oxf.) 21: 299, 1984.

    Article  CAS  Google Scholar 

  13. Davis S.L. Plasma levels of prolactin, growth hormone and insulin in sheep following the infusion of arginine, leucine and phenylalanine. Endocrinology 91: 549, 1972.

    Article  CAS  PubMed  Google Scholar 

  14. Hertelendy F., Takahashi K., Machlin L.J., Kipnis D.M. Growth hormone and insulin secretory responses to arginine in the sheep, pig and cow. Gen. Comp. Endocrinol. 14: 72, 1970.

    Article  CAS  PubMed  Google Scholar 

  15. Fajans S.S., Floyd J.C. Jr, Knopff R.F., Conn J.W. Effect of amino acids and proteins on insulin secretion in man. Rec. Progr. Horm. Res. 23: 617, 1967.

    CAS  PubMed  Google Scholar 

  16. Frasier S.D. A rewiev of growth hormone stimulation tests in children. Pediatrics 53: 929, 1978.

    Google Scholar 

  17. Ghigo E., Miola C., Aimaretti G., Valente F., Procopio M., Arvat E., Yin-Zhang W., Camanni F. Arginine abolishes the inhibitory effect of glucose on the GH response to GHRH in man. Metabolism 41: 1000, 1992.

    Article  CAS  PubMed  Google Scholar 

  18. Maccario M., Ghigo E., Miola C., Bertaina S., Procopio M., Bellone J., Arvat E., Taliano M., Martina V., Camanni F. Influence of arginine, glucose and free fatty acids on the GHRH-induced GH response in man. Ninth International Congress of Endocrinology, Nice, August 30-September 5, 1992, p. 311 (Abstract).

    Google Scholar 

  19. Besset A., Bonardet A., Rondonin G., Descomps B., Passonant P. Increase in sleep related GH and PRL secretion after chronic arginine aspartate in man. Acta Endocrinol. (Copenh.) 99: 18, 1982.

    CAS  Google Scholar 

  20. Cicognani A., Balsamo A., Zucchini S., Tacconi M., Pascucci M.G., Zappulla F., Pirazzoli P., Cacciari E. Trattamento con arginina in bambini con ritardo costituzionale di accrescimento: studio in doppio cieco. Riv. Ital. Pediatr. (IJP) 16: 41, 1990.

    Google Scholar 

  21. Cristiano A.M., Hao E.H., Rose S.R., Municchi G., Ma N., Cassorla F., Merriam G.R. Co-treatment with a beta-adrenergic antagonist can enhance the growth response to growth hormone-releasing hormone (GHRH) therapy in growth hormone (GH) deficient children: a pilot study. 73th Annual Meeting of The Endocrine Society, Washington, June 19–22, 1991, p. 424 (Abstract).

    Google Scholar 

  22. Martha P. Jr, Blizzard R.M., Thorner M.O., Rogol A.D. Atenolol enhances nocturnal growth hormone (GH) release in GH-deficient children during long term GH-releasing hormone therapy. J. Clin. Endocrinol. Metab. 70: 56, 1990.

    Article  PubMed  Google Scholar 

  23. Zadik Z., Chalew S.A., McCarter R.J., Meistas M., Kowarsky A.A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60: 513, 1985.

    Article  CAS  PubMed  Google Scholar 

  24. Rudman. D., Kutner M.H., Rogers M., Lubin M.F., Fleming G.A., Bain R.P. Impaired growth hormone secretion in the adult population. J. Clin. Invest. 67: 1361, 1981.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Vermeulen A. Nyctohemeral growth hormone profiles in young and aged man: correlation with somatomedin-C levels. J. Clin. Endocrinol. Metab. 64: 884, 1987.

    Article  CAS  PubMed  Google Scholar 

  26. Delitala G., Frulio T., Pacifico A., Maioli M. Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man. J. Clin. Endocrinol. Metab. 55: 1231, 1982.

    Article  CAS  PubMed  Google Scholar 

  27. Sassolas G., Chatelain P., Cohen R., Boissel J.P., Laporte S., Claustrat B., Elm Charfi A., Chayvialle JA., Choen H., Ferry S., Underwood E. Effects of human pancreatic tumor growth hormone releasing hormone (hpGRH1-44NH2) on immunoreactive and bioactive plasma growth hormone in normal young man. J. Clin. Endocrinol. Metab. 59: 705, 1984.

    Article  CAS  PubMed  Google Scholar 

  28. Borges J.L.C., Blizzard R.M., Gelato M.C., Furlanetto R., Rogol A.D., Evans W.S., Vance M.L., Kaiser D.L., MacLeod R.M., Merriam G.R., Loriaux D.L., Spiess J., Rivier J., Vale W., Thorner M.O. Effects of human pancreatic tumor growth hormone releasing hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 2: 119, 1983.

    Article  CAS  PubMed  Google Scholar 

  29. Almeida O.F.X., Schulte H.M., Rittmaster R.S., Chrousos G.P., Loriaux D.L., Merriam G.R. Potency and specificity of a growth hormone-releasing factor in a primate and in vitro. J. Clin. Endocrinol. Metab. 58: 309, 1984.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Endocrinologia, Dipartimento di Fisiopatologia Clinica, Università di Torino, Torino

    J. Bellone, E. Arvat, G. Aimaretti, M. Maccario, M. Mucci,  Franco Camanni & E. Ghigo

  2. Divisione di Pediatria, Ospedale di Recanati, Macerata, Italy

    E. Bartolotta, G. Cardinale & V. Cherubini

Authors
  1. J. Bellone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Bartolotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Cardinale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Cherubini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Aimaretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Maccario
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Mucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Franco Camanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bellone, J., Bartolotta, E., Cardinale, G. et al. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. J Endocrinol Invest 16, 521–525 (1993). https://doi.org/10.1007/BF03348897

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348897

Key-words

  • Arginine aspartate
  • arginine hydrochloride
  • growth hormone
  • growth releasing hormone
  • somatostatin